Sim&Cure

Sim&Cure is a digital start-up based in Montpellier, France, founded in 2014. The company is dedicated to revolutionizing endovascular treatments through the utilization of Digital Twin and AI Technologies. Sim&Cure aims to not only improve patient outcomes but also enhance the experience for physicians. The company prides itself on driving innovation within the healthcare industry, ultimately leading to better treatment strategies and patient care.

Sim&Cure's notable achievements include winning the esteemed i-Lab national contest twice in 2014 and 2015 and i-Nov in 2020. The start-up has garnered significant support, with €3.00M Series A investment on 23 May 2019, backed by Elaia Partners and IT Translation. The strategic collaborations with leading laboratories and hospitals globally underscore the company's commitment to advancing endovascular treatments.

With a subsidiary in the United States (New York) established in July 2019, Sim&Cure demonstrates a strong global presence. As the company continues to expand, currently employing 50 people, it anticipates a phase of robust growth in the near future, solidifying its position as a key player in the Health Care industry.